You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
健康元(600380.SH):2021年度淨利預增12%-22%
格隆匯 01-14 17:29

格隆匯1月14日丨健康元(600380.SH)公佈2021年年度業績預吿,經財務部門初步測算,公司預計2021年度實現歸屬於上市公司股東的淨利潤為12.55億元至13.67億元,與2020年度相比,將增加1.34億元到2.46億元,同比增長12%到22%。

預計2021年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為11.41億元至12.37億元,與2020年度相比,將增加1.74億元到2.71億元,同比增長18%到28%。

業績變化主要原因:

(一)主營業務影響:報吿期內,化學制劑板塊銷售增速明顯,呼吸、消化道、促性激素、精神等重點優勢領域銷售同比實現持續快速增長,加之原料藥板塊高端特色原料藥盈利及佔比穩步提升,保障了公司整體業績的穩步增長。

(二)非經營性損益的影響:2020年公司控股子公司麗珠醫藥集團股份有限公司出售了其持有的江蘇尼科醫療器械有限公司全部股權,2021年度非經常性損益同比下降。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account